Objective: To compare proportions of the combined outcome of vertigo control and hearing preservation between intratympanic gentamicin injections and endolymphatic sac shunt surgery for intractable vertigo in Ménière's disease patients.
Study Design: Analysis of published data and retrospective review.
Setting: Tertiary otologic referral center.
Patients: Patients with Ménière's disease who had failed medical management: 183 surgical patients (shunt group) and 203 patients obtained from 6 published gentamicin treatment studies (gentamicin group). Cases were included if hearing and vertigo data were available before and after treatment with no previous surgical or injection treatment. Average patient age ranged from 45 to 59 years across studies. Gentamicin studies had nearly equal female to male subjects, whereas the shunt group was 60% female.
Interventions: Endolymphatic sac shunt surgery or intratympanic gentamicin treatment of differing doses and injection schedules.
Main Outcome Measure: Proportion of patients with best combined vertigo control/hearing preservation. Hearing preservation is 10 dB or less increase in pure-tone average. Outcomes were categorized as follows: complete vertigo control/hearing preservation (best), complete vertigo control/hearing loss, incomplete vertigo control/hearing preservation, and incomplete vertigo control/hearing loss (worst).
Results: The shunt group showed a significantly higher percentage of the best outcome (62%) than the gentamicin group (56%, p
Conclusion: A higher percentage of patients undergoing shunt surgery attained complete vertigo control/hearing preservation relative to intratympanic gentamicin. There continues to be significant variability in gentamicin outcomes, suggesting that the technique requires additional refinement before consistently producing good outcomes.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/MAO.0b013e3181dd13ac | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A Randomised Controlled Trial Comparing Intratympanic Gentamicin with Methylprednisolone in Meniere's Disease with Good Hearing.
Indian J Otolaryngol Head Neck Surg
October 2024
Department of ENT, Christian Medical College, Vellore, Tamil Nadu India.
Unlabelled: A randomized prospective parallel group trial was done to compare the efficacy of intratympanic low dose gentamicin with methylprednisolone in treating intractable unilateral Meniere's disease with serviceable hearing.
Study Design: Randomised prospective parallel group trial.
Setting: Tertiary care centre in South India.
Semicircular canal and vestibular plugging in patients with Meniere's disease: a preliminary study.
Acta Otolaryngol
October 2024
Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, China.
Article Synopsis
- A study aimed to evaluate the safety and effectiveness of simultaneous semicircular canal and vestibular plugging for treating patients with intractable Meniere's disease suffering from vertigo and drop attacks.
- Five patients were observed over six months post-surgery; none experienced recurring drop attacks, and four had no vertigo episodes, indicating promising results.
- The procedure shows potential in alleviating symptoms of Meniere's disease while maintaining hearing function, but more research is needed to validate these findings.
Tympanostomy tube placement for intractable Meniere's disease in the elderly.
Acta Otolaryngol
January 2024
Department of Otolaryngology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.
Background: The treatment of refractory elderly Meniere's disease is a challenge.
Aim: To investigate the efficacy of tympanostomy tube placement in elderly patients with Meniere's disease.
Methods: 31 patients over 60 years old with Meniere's disease who had failed medical treatment and underwent tympanostomy tube placement.
Long-term efficacy of dexamethasone treatment tympanic antrum catheterization for intractable Meniere's disease.
Front Neurol
December 2022
Department of Otolaryngology-Head and Neck Surgery, Shandong Provincial ENT Hospital, Shandong University, Jinan, China.
Objective: To explore the long-term efficacy and safety of dexamethasone treatment tympanic antrum catheterization (TAC) in intractable Meniere's disease (MD).
Methods: In this retrospective analysis, 60 unilateral intractable MD patients treated with TAC in our hospital from January 2020 to August 2020 were followed for 2 years. Fifty patients who underwent endolymphatic sac decompression (ESD) and 50 patients who accepted intratympanic steroids (ITS) were established as the control groups.
Intratympanically administered steroid for progressive sensorineural hearing loss in Ménière's disease.
Acta Otolaryngol
November 2019
Department of Otolaryngology and Head and Neck Surgery, Semmelweis University, Budapest , Hungary.
Ménière's disease is characterised by episodic rotational vertigo, sensorineural hearing loss, tinnitus, and vegetative symptoms. The aim of our study is to follow-up the effects of the intratympanic steroid treatment of hearing loss in MD. A group of 105 clinically diagnosed MD patients were enrolled in this investigation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!